- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04918394
Mold Exposure and Impact on Asthma Control in French Asthmatic Children (CHAMPIASTHMA)
Assessment of Mold Exposure in Asthmatic Children Follow-up in Nord and Pas-De-Calais Departments, France, and Impact on Asthma Control
Observational, multicenter, study conducted in 12 hospitals in the Nord and Pas-De-Calais departments. The aim of this study is to describe the relationship between reported exposure to molds and asthma control in a pediatric population.
Each patient followed by a specialized asthma pediatrician in one of the study center will be proposed to participate in the study.
Children aged 1 to < 18 years, with asthma diagnosis, based on the assessment of a specialized physician after a follow-up of at least 6 months Inclusion, non-inclusion and exclusion criteria will be verified by the investigators. The questionnaires will be completed during the consultation, collected by the physician in charge of the consultation and sent to the principal investigator for data entry.
Inclusion will take place over a period of 12 consecutive months from the date of obtaining regulatory approval.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
-
Armentières, França
- Ch Armentieres
-
Boulogne Sur Mer, França, 62321
- Ch Boulogne-Sur-Me
-
Calais, França
- Ch Calais
-
Dunkerque, França, 59385
- CH Dunkerque
-
Lens, França
- Centre Hospitalier de LENS
-
Lille, França, 59037
- Hop Jeanne de Flandre Chu Lille
-
Lille, França
- Centre Hospitalier St Vincent
-
Roubaix, França
- Centre Hospitalier de Roubaix
-
Seclin, França
- Centre Hospitalier de Seclin
-
Valenciennes, França
- Centre Hospitalier,
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Children aged 1 to < 18 years, with asthma diagnosis, based on the assessment of a specialized physician after a follow-up of at least 6 months, Follow-up in one of the study center in Nord and Pas de Calais departments (Lille, Lens, Tourcoing, Valenciennes, Arras, Roubaix, Seclin, Armentières, Calais, Boulogne/mer, Dunkerque, GHICL-Saint Vincent) over an inclusion period of 12 months
Exclusion Criteria:
- Children living ≤ 50% of the weekly time in their primary home (e.g., shared custody)
- Children whose living arrangement characteristics are difficult to analyze (e.g., child accompanied by grandparents or by the parent without primary custody)
- Children whose residence has recently changed, making it impossible to assess the impact of the living arrangement over the past year
- Children living outside of the Nord and Pas-de-Calais departments
- Children whose parents are unable to complete the questionnaire
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
---|---|
Asthma patients unexposed to mold / moisture
No mold / moisture exposure is defined by a negative response to all of the 5 following questions, asked in the form of a parent-completed declarative questionnaire regarding the child's primary living home.
|
Mold / moisture exposure is assessed by the 5 following questions, whose positive response has been associated with the actual presence of mold in the household (according to data from the literature data), asked in the form of a parent-completed declarative questionnaire regarding the child's primary living home:
|
Asthma patients exposed to mold / moisture
Mold / moisture exposure is defined by a positive response to at least one of the 5 following questions, asked in the form of a parent-completed declarative questionnaire regarding the child's primary living home.
|
Mold / moisture exposure is assessed by the 5 following questions, whose positive response has been associated with the actual presence of mold in the household (according to data from the literature data), asked in the form of a parent-completed declarative questionnaire regarding the child's primary living home:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Asthma control according to GINA guidelines
Prazo: At the time of inclusion
|
The Global Initiative for Asthma (GINA)guidelines: Well controlled Partly controlled Uncontrolled |
At the time of inclusion
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Asthma control according to Asthma Control Test (ACT) score in children aged 12 years and older: Controlled if ACT ≥ 20
Prazo: At the time of inclusion
|
Asthma Control Test: Each question is assigned a score between 1 and 5 (the score for the first answer proposal is 1, the second is 2, and so on).
The score of the 5 questions is added up to a total score that can vary between 5 and 25.
The higher the total score, the better the asthma is controlled.
|
At the time of inclusion
|
Asthma control according to pACT score in children aged 1 to 11 years old: Controlled if ACT ≥ 20
Prazo: At the time of inclusion
|
At the time of inclusion
|
|
Asthma treatment step according to GINA guidelines: Step 1 to step 4 in children aged < 6 years Step 1 to step 5 in children aged ≥ 6 years
Prazo: At the time of inclusion
|
At the time of inclusion
|
|
Inhaled corticosteroid doses in µg/day of fluticasone
Prazo: At the time of inclusion
|
At the time of inclusion
|
|
Acute asthma events in the past 12 months
Prazo: At the time of inclusion
|
Acute asthma events: emergency room visits, hospitalization, general corticosteroid course
|
At the time of inclusion
|
Exposure to other indoor pollutants: cigarette smoke (declarative smoking by at least one of the parents)
Prazo: At the time of inclusion
|
At the time of inclusion
|
|
Exposure to indoor allergens: declarative exposure to animal danders
Prazo: At the time of inclusion
|
At the time of inclusion
|
|
Exposure to indoor allergens: declarative exposure to house dust mite (carpet, mattress)
Prazo: At the time of inclusion
|
At the time of inclusion
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Antoine DESCHILDRE, MD,PhD, University Hospital, Lille
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2019_49
- 2019-A03310-57 (Outro identificador: ID-RCB number,ANSM)
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Asma em Crianças
-
Meshalkin Research Institute of Pathology of CirculationAinda não está recrutandoas Propriedades de Força da Aorta in Vivo | as propriedades de resistência da aorta in vitro | Modelo de Regressão das Propriedades de Força Aórtica in Vitro e in VitroFederação Russa
-
Organon and CoConcluídoFertilização in vitro
-
Boston Scientific CorporationAtivo, não recrutando
-
Centre Hospitalier Universitaire de NīmesConcluído
-
Kaohsiung Veterans General Hospital.Concluído
-
Kaohsiung Veterans General Hospital.Concluído
-
Adiyaman UniversityConcluído
-
Rabin Medical CenterDesconhecido
-
Istituto Clinico HumanitasConcluído
-
Suleyman Demirel UniversityDesconhecidofertilização in vitroPeru